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MRC Human Genetics Unit, The Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK
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Abstract
ELIXIR is the European infrastructure established specifically for the sharing
and sustainability of life science data. To provide up-to-date resources and
services, ELIXIR needs to undergo a continuous process of refreshing the
services provided by its national Nodes. Here we present the approach taken
by ELIXIR-UK to address the advice by the ELIXIR Scientific Advisory Board
that Nodes need to develop “mechanisms to ensure that each Node continues
ELIXIR-UKto be representative of the Bioinformatics efforts within the country”. 
put in place an open and transparent process to identify potential ELIXIR
resources within the UK during late 2015 and early to mid-2016. Areas of
strategic strength were identified and Expressions of Interest in these priority
areas were requested from the UK community. Criteria were established, in
discussion with the ELIXIR Hub, and prospective ELIXIR-UK resources were
assessed by an independent committee set up by the Node for this purpose. Of
19 resources considered, 14 were judged to be immediately ready to be
included in the UK ELIXIR Node’s portfolio. A further five were placed on the
Node’s roadmap for future consideration for inclusion. ELIXIR-UK expects to
repeat this process regularly to ensure its portfolio continues to reflect its
community’s strengths.
 
This article is included in the ELIXIR Reports
channel.
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Introduction
ELIXIR, the European infrastructure for life science data1, is 
made up of individual Nodes, one for each of the organisation’s 
constituent members (21 as of 1st March 2017: Belgium, Czech 
Republic, Denmark, EMBL-EBI, Estonia, Finland, France, 
Germany, Hungary, Ireland, Israel, Italy, Luxembourg, Netherlands, 
Norway, Portugal, Slovenia, Spain, Sweden, Switzerland and 
the UK), and a coordinating hub. The individual ELIXIR Nodes 
provide the services and resources that support the five pillars of 
ELIXIR (Compute, Tools, Data, Interoperability and Training 
infrastructures). ELIXIR Services can be data resources, tools, and 
services, such as interoperability services or training centres.
ELIXIR nodes need to be able to evolve their contributions to 
ELIXIR by bringing new services and resources. ELIXIR identi-
fies two types of service: Node-funded services, which are funded 
nationally and are contributed to ELIXIR from a national Node; 
and Commissioned Services, which are funded by ELIXIR as a 
whole via the ELIXIR Hub. In some ELIXIR Nodes, Node-funded 
services receive funds through their national Nodes; in the case of 
the UK’s Node, ELIXIR-UK, resource funding is through direct 
grant funding to resources and services from the national funders. 
In ELIXIR terms, these are still labelled as “Node-funded”. The 
process described in the present article was set up to identify Node-
funded services and resources for ELIXIR-UK. In this context it 
should be noted that the services a Node can contribute to ELIXIR 
may fall under any one of ELIXIR’s five platforms: tools, data, 
compute, interoperability and training. ELIXIR-UK took a strate-
gic decision to exclude potential compute resources from this proc-
ess, at least initially, pending national commitment to contribute 
compute resources to international programmes. ELIXIR sets high 
standards for the services it provides. Consequently, nodes need to 
take full account of these requirements when selecting and propos-
ing their services, which are ultimately judged for suitability by the 
ELIXIR Scientific Advisory Board (SAB) and Board of ELIXIR 
(see the online ELIXIR Handbook for more detail).
ELIXIR-UK was established in September 2013, and as its first 
contribution to ELIXIR took on a thematic focus, namely of coor-
dinating training activity. More recently, it has sought to expand 
its remit. To address the SAB’s recommendation that Nodes put in 
place “mechanisms to ensure that each Node continues to be 
representative of the Bioinformatics efforts within the country”. 
The UK’s bioinformatics landscape is diverse with strengths across 
the range of ELIXIR’s activities. UK bioinformatics research is pri-
marily supported either by grant funding to research groups based in 
Universities or to longer-term, rolling funding to groups in research 
institutes. Although there are some dedicated funding sources for 
bioinformatics resources (notably the BBSRC’s Bioinformatics and 
Biological Resources Fund and the Wellcome Trust’s Biomedical 
Resources Development Grants) much development, particularly 
of bioinformatics tools, is carried out as part of 3-year or shorter 
research grants. Long-term sustainability of new resources is there-
fore an ongoing issue for the UK bioinformatics community, as it 
is in other territories. UK funders have a range of interests and a 
commitment to fundamental research but some areas are particu-
larly well-supported: health and welfare-related research receives 
dedicated funding via the MRC and from the Wellcome Trust, and 
BBSRC focusses significant resource into research relating to food 
security (primarily agricultural animals and plants). The UK has 
particular and long-standing strengths in genomics and structural 
biology. It is worth noting that the European Bioinformatics Insti-
tute (EBI), which is located in the UK, is not part of the UK Node 
of ELIXIR but it is a frequent partner in UK-funded research grants. 
Many UK resources likely to become part of the UK Node have 
established links with the EBI.
To reflect this diversity, and its perceived strengths, ELIXIR-UK 
developed a process to choose new services and resources to add to 
its existing portfolio that would:
•    Reflect national strengths and priorities in bioinformatics
•    Engage its national community; and
•    Be robust, transparent and open so that its community would 
regard it as fair and it could continue to be applied to allow 
the Node to develop over time.
Process overview
As illustrated in Figure 1, the process implemented by ELIXIR-UK 
went through seven key phases, which are expanded on in the fol-
lowing sections:
1. Strategic prioritization
2. Identifying possible candidate resources
3. Establishing a Scientific Development Group to provide 
external advice on the suitability of candidate resources
4. Establishing assessment criteria
5. Engaging the community
6. Assessing Expressions of Interest
7. Finalising a new portfolio
Strategic prioritization
The requirement to ensure that each Node continues to be repre-
sentative of the Bioinformatics efforts within the country could 
be seen as open ended, and thus could ultimately lead to an ill-
focussed collection of resources and services. To avoid this, 
ELIXIR-UK identified a set of priority areas within which to 
focus submissions to the process (in this context, and when 
      Amendments from Version 1
We believe we have responded to all the comments raised by the 
reviewers and that this version of the manuscript is improved as 
a results. In particular the reviewers were keen that we explained 
better (and in some cases clarified) the criteria that were used to 
assess resources during this exercise. To improve understanding 
of this we have included an additional table that goes into more 
detail about the interpretation of the criteria we applied. We 
have also included an altered Figure 1 which places the various 
activities that took place during our process in a timeline.  
See referee reports
REVISED
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Figure 1. Summary timeline of the ELIXIR-UK Node Expansion process. Bulleted items represent milestones in the process; arrows below 
represent the three main phases: engaging the community and identifying potential applicants to invite (the call was also open to non-invited 
applications); receipt of applications; and assessment of applications by the SDG including feedback and iteration with applicants.
discussing any other decisions made by ELIXIR-UK, note that 
decisions were formally made by the Node Executive Commit-
tee which consisted of the Head of Node, Deputy Head of Node, 
Node Coordinator, Technical and Training Coordinators and three 
rotating members; the constitution of the Node will change in 2017 
and this Executive Committee will be replaced by Management 
and Steering Committees which will take on final decision-making 
responsibility). These were initially identified by discussions 
within the Node and were refined by discussion with the Node’s 
funding organisations (Biotechnology and Biological Sciences 
Research Council [BBSRC], Medical Research Council [MRC] 
and Natural Environment Research Council [NERC]) and with the 
Scientific Development Group (SDG), which was a community 
body set up by the Node that is tasked with identifying new node 
resources (see below).
As a consequence of these discussions, Expressions of Interest 
(EoIs) were invited in the following priority areas, identified as 
being of high strategic importance within the UK:
•     Human clinical and health ‘omics and related areas in health 
informatics
•     Agricultural ‘omics and related data resources
•     Image informatics (including atlases)
•     Structural bioinformatics
•     Technical infrastructure for interoperability and training 
including standards
Identifying possible candidates
ELIXIR-UK aimed to reconcile two potentially conflicting driv-
ers in developing its expansion process. Firstly, it wanted to be 
as open to the UK bioinformatics community as it could. This is 
an ongoing challenge because a) ELIXIR has incomplete brand 
recognition within the UK community, and b) is not well-regarded 
by some, being seen either as a closed club or unproductive. 
Secondly, the Node wanted to ensure it received Expressions of 
Interest from potential services and resources that were demonstra-
bly of high value to the international life sciences community. To 
address these requirements, the Node approached the recruitment 
of potential candidates in two ways. Firstly, it publicised its “Node 
Expansion” process well in advance using its web site, Twitter and 
word-of-mouth. Secondly, it sent targeted emails to potential candi-
date resources. These were identified using a variety of inputs:
•     Brainstorming by members of the existing node
•     Setting up a specific working group - on Agriculture- 
related data - for an area that was not well-represented in 
the current node
•     Additional suggestions from the SDG (see next section) 
and funders
The Scientific Development Group
The key body in the Node’s expansion process was the SDG. This 
was set up by the Node to evaluate EoIs to join the Node against a 
set of published criteria (see below). This group was also involved 
in refining those criteria and providing suggestions of resources to 
be invited to provide EoIs.
The membership of this group was based on suggestions from 
within the Node and from its funders. The members of the group 
are listed in the acknowledgements section. The group’s compo-
sition reflected the priority areas identified for the expansion, 
geographic spread, and the inclusion of at least one industry and 
at least one overseas representative. The Chair was chosen for 
his experience as a senior officer of a UK funding agency and 
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knowledge of appropriate processes for activities of this kind. 
For the record we note that the group did not have an appropriate 
gender balance (it was 100% male). This is a defect we intend to 
remedy in future.
Assessment criteria
Over time ELIXIR has been evolving both its classification of 
resources and its criteria for selecting them. During the period of 
the UK Node’s expansion process these definitions and criteria 
continued to evolve. The assessment criteria developed by ELIXIR-
UK were developed by internal discussion within the Node’s 
Executive and in discussion with the SDG and were also discussed 
informally with the leaders of Work Package 3 of the EXCELER-
ATE programme (Jo McEntyre and Christine Durinx), as their 
criteria developed in parallel (the WP3 criteria were not available 
for consideration by the Node in detail when it was developing its 
criteria but the WP3 leadership confirmed to us that our criteria 
were similar to theirs). EXCELERATE Work Package 3 aims to 
identify key data resources across Europe and support the linkages 
between data and the scientific literature. The final set of criteria, 
which were provided to applicants as an openly shared Google 
document, were:
1.      Alignment with the five ELIXIR infrastructure themes 
(data, tools, compute, interoperability, training)
2.      Strong complementarity to the 2014-18 ELIXIR 
programme
3.      Complementarity to ELIXIR-UK strategic themes
4.      Potential for cross-Node collaborations
5.      Provision of comparable impact to existing ELIXIR 
resources from other Nodes already accepted by the ELIXIR 
SAB
6.      Resource contribution to wider EU infrastructures and 
integration
7.      Ability to interoperate with other ELIXIR resources
8.      Evidence of community outreach and adoption
9.      Leadership in data stewardship within a community
10.    Evidence of long-term sustainability
To facilitate applicants demonstrating that their resources fulfilled 
these criteria, an Expression of Interest template form was provided 
(see Supplementary file 1). EoIs were received on a confidential 
basis.
The criteria developed by EXCELERATE Work Package 3 have 
subsequently been finalised and form the basis of the ELIXIR proc-
ess for selection of Core Data Resources2.
Criteria for training resources were necessarily different for those 
for data, tools and interoperability resources. Criteria 1-4 applied as 
for other resources as these concern compatibility with ELIXIR’s 
strategy and activities. Criterion 5 could not be directly applied as 
other Nodes did not at that time offer training centres as resources, 
but the principle of comparable quality to other ELIXIR training 
activities was applied. Criterion 6 was relevant in that training 
resources needed to have an outward-looking approach and should 
not only provide training locally. Criterion 7 was not directly 
applicable but Criterion 8 was a key indicator of quality. Criterion 9 
was relevant where centres showed leadership, e.g. in the ELIXIR 
Training Platform or in coordinating training activities more 
widely. Sustainability of training activities (Criterion 10) is 
generally different for training activities which (in the UK) do 
not generally receive strategic funding to provide training but 
rather are expected to be self-funding. A record of successful 
self-funding over a period of time was therefore expected.
Engaging the community
As outlined, it was important to ensure community buy-in to this 
process (in order to ensure that the Node was able to engage suf-
ficient high quality resources) and at the same time it was important 
to be sure that community members who might be interested in 
participating in ELIXIR-UK were aware of what was required and 
the expectations that would be placed on them as ELIXIR-UK 
Node resources. Formal community engagement took place in 
two phases: a webinar, led by the Head of Node (CAG) and Node 
Coordinator (JMH), in February 2016 and a workshop, hosted at 
the Wellcome Trust building in London, in March 2016. The aim 
of the webinar was to introduce ELIXIR and ELIXIR-UK and the 
rationale behind the node expansion process. The aim of the work-
shop was to introduce and discuss the assessment criteria in detail, 
so that potential applicants could be clear as to what was required. 
The presentation given at the workshop is available via Slideshare. 
At this stage a deadline was set for the receipt of Expressions of 
Interest by the Node. It is worth noting that the deadlines for the proc-
ess were tight: EoIs were requested by the end of March 2016 and 
the assessment meeting took place at the end of April with some 
iterations taking place in May. We were fortunate in being able to 
run such a tight schedule due to a) clear and lightweight require-
ments for the EoIs; b) what we believe to be clear and effective 
communications; and c) motivated applicants and SDG members.
One result of being open to community input was that the origi-
nal scope of the call – for data, tools and interoperability resources 
– was broadened to include also training resources. This was done 
because existing members of the Node who were providing train-
ing wished to be recognised on the same basis as providers of more 
technical types of resource. The training resources considered dur-
ing the process were of two types: providers of training courses and 
training infrastructure.
Assessment of Expressions of Interest
EoIs were assessed by the SDG against the published set of cri-
teria. To facilitate assessment of EoIs, three group members were 
allocated to each EoI (18 were submitted). The three members 
were asked to score EoIs from 1 to 4: 1 = ready for inclusion in 
ELIXIR (“infrastructure ready”); 2 = further discussion or clarifi-
cation needed; 3 = not ready, but suitable enough to be placed on 
a roadmap for future inclusion; 4 = not suitable. The assessments 
for each EoI were introduced by one member of the group leading 
on to an open discussion. Representatives of the Node funders and 
the ELIXIR-UK executive observed the meeting to give advice on 
strategic alignment. EoIs were given a consensus final score using 
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the same scale as before, with a score of 2 in this case represent-
ing the need for further clarification of issues raised by the group. 
Resources given a 2 rating were asked for further information, 
which led to their final score being revised upwards or downwards 
in a subsequent iteration.
Four of the five strategic areas that were laid out initially received 
three or four Expressions of Interest. The one receiving fewer EoIs 
was the theme on Image Informatics, for which only one proposal 
was received (although we note that the Biomedical Atlas Centre 
was explicitly formed to address this call). Although we speci-
fied strategic priorities we also informed potential proposers that 
we were open to proposals outside of these priority areas. Conse-
quently, and reflecting ELIXIR-UK’s involvement with the ELIXIR 
Training platform, we received enquiries as to whether we would 
also consider EoIs from training centres. In the spirit of supporting 
the widest possible engagement within ELIXIR-UK we agreed to 
this suggestion and received three proposals for training centres, all 
of which were accepted.
A point to note is that a number of the resources that were con-
sidered are not UK-only – many are joint activities that span dif-
ferent countries, some with their own ELIXIR Node. This was a 
Table 1. Notes on the ways in which the SDG applied the general requirements of the ten assessment criteria.
Criterion Comments
1. Alignment with the five ELIXIR 
infrastructure themes (data, tools, 
compute, interoperability, training)
These two criteria supplied a high-level test as to whether proposals described the kinds of 
resources that could be envisaged as contributing to ELIXIR a) as bioinformatics resources and 
b) as fitting within the realm of activity of ELIXIR. As an example, a training centre focussing on in 
biochemistry wet lab techniques would pass criterion 1 but not criterion 22. Strong complementarity to the 
2014-18 ELIXIR programme
3. Complementarity to ELIXIR-UK 
strategic themes
This more stringent test assessed whether there was clear complementarity between the data, 
tools, interoperability or training provided by the resource and the strategic themes identified by 
ELIXIR.
4. Potential for cross-Node 
collaborations
Potential resource were assessed as to whether they currently interacted with resources provided 
by other Nodes (noting that information on this was only sketchy when the assessment was carried 
out) or more broadly if they interacted with resources in other ELIXIR countries
5. Provision of comparable impact 
to existing ELIXIR resources from 
other Nodes already accepted by 
the ELIXIR SAB
This criterion was used to gauge the level of international recognition resources had, and how 
important they were to their communities. High importance to a small community was considered 
as important as reach to a wider community. One aspect of this assessment was usage metrics. 
Use of metrics currently suffers from lack of consistency between resources; generally successful 
data resource achieved the equivalent of 10,000 unique users per annum.
6. Resource contribution to wider 
EU infrastructures and integration
The degree to which resources could claim to contribute to wider EU infrastructures was generally 
limited. Generally responses to this criterion represented aspirations to interact more as part of 
ELIXIR.
7. Ability to interoperate with other 
ELIXIR resources
This was a test of whether technical resources used or provided metadata standards or APIs that 
were open to external users including ELIXIR resources, or intended to move in that direction. 
Technical standards for ELIXIR were in their earliest stages when this assessment was carried out 
so a clear mapping to Interoperability Platform recommendations was not possible.
8. Evidence of community 
outreach and adoption
Two main aspects were considered under this criterion – the amount of community usage and 
recognition, and the outreach activities the resources provided, including training.
9. Leadership in data stewardship 
within a community
This was more relevant in some cases – when a resource was a major resource or repository for a 
single community – than for others where their resource provision was more cross-cutting.
10. Evidence of long-term 
sustainability
Evidence of sustainability considered was twofold – firstly the track record of past funding and 
current funding commitment and secondly any institutional commitment to support the resource. 
At least one resource’s case was weakened by lack of current funding. Shifts in institutional 
funding from UK funders mean that there is little opportunity for stable, long-term funding from 
institutes even when these are funder-branded because of (typically) 5-year funding renewals.
topic of some discussion in the SDG meetings as ELIXIR-UK is 
intended to represent UK contributions. On the other hand, exclud-
ing international activities per se could have the effect of preventing 
some valuable resources from becoming part of ELIXIR. The SDG 
decided to include resources if they could make the case that they 
were primarily based in the UK or the UK contribution was sig-
nificant and the resource was unlikely to be put forward by another 
ELIXIR Node.
Table 1 contains some comments on how each of the criteria were 
applied during the assessment process.
Results of the assessment
The outcomes of the assessment are summarised in Table 2. Nine 
EoIs were considered to be infrastructure ready (score of 1) on the 
first pass of assessment, and a further five were asked for more 
detail on their proposal (score of 2).
An iteration of discussions with resource scientists allowed 
questions raised by the SDG to be considered further. Where 
these were answered satisfactorily, resources were moved up 
to infrastructure-ready status. Otherwise they were put on 
the roadmap or, in one case, referred to the ELIXIR SAB for 
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Table 2. Summary of outcome of 
the Scientific Development Group 
deliberations. The table gives numbers 
of proposals classified as 1 (ready 
for inclusion in ELIXIR (“infrastructure 
ready”);  2 (further discussion or 
clarification needed); 3 (not ready, 
but suitable enough to be placed on 
a roadmap for future inclusion); 4 (not 
suitable).
Rating After panel 
assessment After iteration
1 10 13
2 5 1*
3 4 5
4 0 0
*In this case the group were unclear whether 
the proposed resource could be included 
in the Node’s offering. This case was put 
forward to the ELIXIR SAB for further input who 
recommended it be placed in Category 1.
further comment (in this latter case, SAB guidance subsequently 
resulted in it being accepted as infrastructure ready).
After ratification by the ELIXIR-UK executive and notification 
to the ELIXIR Hub, highly rated resources were included 
directly into the Node’s portfolio and were included in the Node 
Application presented to the ELIXIR SAB in June 2016 and the 
ELIXIR Board in November 2016. Others were placed on the 
Node’s roadmap for possible future inclusion.
The services and resources selected as ready for immediate 
inclusion are listed in Table 3.
Future activities and conclusions
We believe that the process outlined here was open, transpar-
ent and fair. We carried out a survey of proposers, SDG members 
and other members of ELIXIR-UK which strongly supported this 
view. It also identified two areas that we will need to pay atten-
tion to in future: the quality of feedback to proposers, especially 
unsuccessful ones (i.e. those which are roadmapped), and how 
widely the exercise is advertised to attract applicants. We note 
Table 3. Resources judged to be ready for inclusion in ELIXIR at the end of the assessment process. Resources are classified 
by strategic themes within ELIXIR-UK.
Name Strategic theme URL
Ensembl – farmed and domesticated 
animals3
Agri-food data www.ensembl.org
Pathogen Host Interactions Database 
(PHI-base)4
Agri-food data http://www.phi-base.org
Biomedical Atlas Centre Gene expression 
atlases
http://emouseatlas.org/, 
http://hudsen.org/, 
http://echickatlas.org/
IUPHAR/BPS Guide to Pharmacology5 Human health  
& disease data
www.guidetopharmacology.org
BioSharing6 Interoperability 
services
https://biosharing.org
InterMine7 Interoperability 
services
http://www.intermine.org,  
https://github.com/intermine/intermine
ISA Tools & Commons8 Interoperability 
services
http://www.isa-tools.org  
http://www.isacommons.org
CATH-Gene3D9 Protein structure & 
function
http://www.cathdb.info/
Jalview and the Dundee Resource 
for Sequence Analysis and Structure 
Prediction10
Protein structure & 
function
www.jalview.org  
www.compbio.dundee.ac.uk/jpred
Phyre211 Protein structure & 
function
www.imperial.ac.uk/phyre2
Birmingham Metabolomics Training 
Centre
Training http://www.birmingham.ac.uk/facilities/metabolomics-training-centre/
index.aspx
Cambridge Bioinformatics Training 
Programme
Training http://bioinfotraining.bio.cam.ac.uk/  
http://training.csx.cam.ac.uk/bioinformatics/Event-timetable
Edinburgh Genomics Advanced 
Training in Bioinformatics
Training https://genomics.ed.ac.uk/services/training
TeSS (Training e-Support System) Training https://tess.elixir-uk.org/
*References for the databases/tools have been added where available.
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that the “success rate” of the process was high. No resources were 
rejected outright and more than 70% were promoted immediately 
to the Node’s portfolio. This does not reflect a lax process, but 
is likely to have had a number of contributing factors, including:
•     The fact that this was the first call of this kind meant that 
the Node could call on a number of outstanding, 
internationally-acknowledged resources. The resources 
placed on the roadmap were generally also well regarded, 
but usually in an early phase of their development. 
Our expectation is that most of these will be recognised 
as Node-funded resources in future.
•     There was a clear explanation and open presentation of the 
high standards expected of successful resource. Therefore, 
it is likely that only resources that considered they had a 
realistic chance of success after the webinar and workshop 
put their names forward. Consequently, we did not receive 
any truly speculative proposals.
Another aspect of the process we outline here is the short time 
period over which it was carried out. In particular, resources were 
only given four weeks to submit EoIs. A number of features of the 
process facilitated this: clear timelines, clear guidance as to what 
was required, the availability of a template for EoIs that helped 
proposers to compile their EoIs, and lightweight requirements for 
completing EoIs, which were nevertheless sufficient to allow the 
SDG to carry out its work effectively. Engagement at a senior level 
by both the Node and proposers was also important. It was also 
important to organise meetings, especially of the SDG, sufficiently 
ahead of time to allow members to both assess the EoIs and attend 
the meetings, either in person or remotely.
We expect this process to be readily generalizable to other ELIXIR 
Nodes who wish to evaluate candidate resources. One limiting fac-
tor for smaller Nodes could be critical mass of potential review-
ers so that it might be necessary to bring in a higher proportion 
of reviewers from outside the country concerned (the UK is for-
tunate in having a large pool of potential assessors not currently 
involved in ELIXIR; this could become more problematic as more 
UK groups participate in ELIXIR-UK. As an example, one of our 
SDG members in 2016 was PI of a resource that was selected for 
inclusion. The applicant was asked to leave the room while their 
resource was discussed as is normal in UK grant assessment 
panels but clearly minimising overlap between applicants and 
assessors is critical). This process also benefitted from close inter-
actions that exist between the Node and its funders, which allowed 
ELIXIR-UK to have a clear picture of its funders’ priorities in set-
ting its own strategic priorities. On the other hand Nodes might 
decide to address ELIXIR-wide or other sets of priorities instead of 
or as well as national priorities.
To maintain and continue to improve the Node’s alignment with 
UK research strengths, it plans to hold regular refresh exercises 
to introduce new resources into the Node. Plans for how this will 
be done are currently under development. To pursue this process 
we expect that we will need to develop community engagement in 
the specific priority areas, so that potential proposers are primed. 
To complement this it will be necessary to continuously evaluate 
the performance of the Node resources that have been selected to 
ensure that they continue to meet the Node’s quality guidelines. 
ELIXIR-UK is in the process of establishing a new constitution 
under which quality assessment of the Node’s offerings to ELIXIR 
will be supervised by its Science and Industry Advisory Board. It is 
likely this body, or a subcommittee of it, will be tasked with carry-
ing out periodic assessments of delivery by Node resources.
An important aspect for the future will be supporting roadmapped 
resources in achieving full Node resource status and possibly, in 
future, status as ELIXIR Core Data Resources. The requirements 
for this will be specific for different resources but two aspects we 
have identified are the ability to discuss potential integration into 
ongoing ELIXIR activities (in particular in light of funding for net-
working activities being limited for many resources) and improved 
technical capabilities, including APIs and use of ELIXIR-compliant 
standards to facilitate technical integration into the ELIXIR data 
ecosystem. We are endeavouring to establish funding streams to 
support developments of this kind.
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Version 1
 23 January 2017Referee Report
doi:10.5256/f1000research.11283.r18696
 Janet Kelso
Department of Evolutionary Genetics, Max Planck Institute for Evolutionary Anthropology, Leipzig,
Germany
This manuscript describes the process whereby the UK node of ELIXIR identifies and prioritises services
for inclusion in the node.
It is an important contribution as it is the first time a strategy for service identification and prioritization has
been documented for an ELIXIR nodes, and it may be able to be generalized for use by other nodes of the
ELIXIR network. It would be good if the authors could comment on the extent to which this approach is
generalizable to other nodes, and on whether there are aspects that are unique to the UK node.
 
The authors should clarify early on that the ‘services’ that ELIXIR nodes may offer may include any
combination of software, data resources and training. This is implied, but may not be completely
clear to readers unfamiliar with ELIXIR.
The authors focus primarily on a process to include new services to the UK ELIXIR node. It would
be good to add a brief section that discusses long-term evaluation of existing services in order to
assess ongoing quality and relevance, and to plan for retirement of services as required.
There are places where it is unclear who represents “the Node” eg: “These were initially identified
by discussions within the Node” and “Brainstorming by members of the existing node”. It may be
useful to explain who is responsible for the Node and decisions taken by “the Node”, and therefore
for the strategic prioritization and evaluation.
Could the template for EoI be made available for other nodes wishing to follow a similar process?
It would be useful to expand briefly on what “Work Package 3 of the EXCELERATE programme
,” is, so that a reader unfamiliar with ELIXIR can understand the relevance.
The authors conclude that the process was transparent and fair. Has there been any
community-feedback on the process? It would be interesting to know how well-accepted the
process has been, and whether there are any suggestions for improvement.
It would be useful to include information about the matching of the EoIs received with the strategic
priorities that were identified. Were applications received in all priority areas? Are there areas that
are not yet represented? How do new services that have been included relate to those that were
already existing within the node, and also to services provided by other nodes (and was this a
consideration in the evaluation process?)
Is there any plan to support service proposals that were assigned to the roadmap for future
inclusion?
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
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 I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 I am a member of the ELIXIR Scientific Advisory Board.Competing Interests:
Author Response (   ) 27 Mar 2017Member of the F1000 Faculty
, ELIXIR-UK Group, Earlham Institute, UKJohn Hancock
In response to this review we have:
Added a section on the extent to which this approach is generalizable to other nodes, and
on whether there are aspects that are unique to the UK node
 
Clarified that the ‘services’ that ELIXIR nodes may offer may include any combination of
software, data resources and training
 
Commented briefly on the long-term evaluation of existing services in order to assess
ongoing quality and relevance, and to plan for retirement of services as required. This will
rely on regular assessments by our Scientific Development Group and SAB
 
Clarified who is responsible for the Node and decisions taken by “the Node” - namely the
Node Executive (now renamed as the Management Committee)
 
Made the template for Expressions of Interest available as supplementary material
 
Expanded briefly on the role and significance of Work Package 3 of the EXCELERATE
programme
 
Added some comment on community-feedback on the process - we carried out a survey
that was supportive although it did suggest two areas for improvement in future: wider
advertising and better feedback to proposers
 
Included an overview of the matching of the EoIs received with the strategic priorities that
were identified
 
We also added a discussion of how we intend to support service proposals that were
assigned to the roadmap for future inclusion
 NoneCompeting Interests:
 09 January 2017Referee Report
doi:10.5256/f1000research.11283.r18698
 Alfonso Valencia
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  Alfonso Valencia
Structural Biology and Biocomputing Programme, Spanish National Bioinformatics Institute (INB),
Spanish National Cancer Research Centre (CNIO), Madrid, Spain
The report describes the process of selection of the UK-ELIXIR xxxx to be presented to the ELIXIR SAB.
The report is very informative and being the first node that describes in detail their national process, it has
the potential to be very useful for nodes in other countries.
I have a number of suggestions of additional information that is mentioned in the text but not
explicitly included.  
Composition of the Scientific Development Group (SDG)
A figure with the time line of the process that could be integrated with the Fig. 1.
The template used for the EoIs.
The EoIs submitted by the selected resources (if possible)
I also have a few other questions that may help to clarify specific aspects.
Three training resources were finally selected but in the description of the UK-ELIXIR strategic
items training is not described separately (´Technical infrastructure for interoperability and
training including standards). If possible, it may help to clarify what was understood by training in
the strategic items and how it is different, or not, of the technical infrastructure.
If it would be possible to give some additional explanation to some of the ' final set of criteria’ that may
really help others. One possible way might be providing examples of answers provided by some of the
applications.
It is not very clear how the 'ELIXIR criteria for the selection of Core Data Resources' was incorporated in
the process. Given the importance of the ELIXIR guidelines for future similar processes this point could be
quite relevant.
Finally, even if I realise that this might be considered outside the scope of this paper,  what will be really
interesting is to include a short explanation of how the selected resources fit each one of the selection
criteria, at least at some level of detail.
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
 No competing interests were disclosed.Competing Interests:
Author Response (   ) 27 Mar 2017Member of the F1000 Faculty
, ELIXIR-UK Group, Earlham Institute, UKJohn Hancock
In response to this review:
We note that the composition of the Scientific Development Group is listed in the
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 We note that the composition of the Scientific Development Group is listed in the
Acknowledgements
 
Revised Figure 1 to put it in the form of a timeline, as requested
 
As noted in our response to the first reviewer, we have provided the EoI template as
supplementary material
 
We cannot make the EoIs themselves available as they were provided to us on a
confidential basis.
 
We have included a description of how training resources were dealt with in the process. As
the reviewer notes, some criteria were less applicable to training resources but others
remained applicable
 
We have included an additional table which summarises how the criteria were interpreted
and applied by the SDG during assessment of resources
 
Expanded a little on how the 'ELIXIR criteria for the selection of Core Data Resources' were
incorporated in the process although this was a relatively informal process
 
We hope the reviewer will find these changes acceptable. 
 NoneCompeting Interests:
 30 December 2016Referee Report
doi:10.5256/f1000research.11283.r18697
 Christine Durinx
SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland
The article is clear and well written. The figure and tables support the content.
Some suggestions, mainly to improve clarity:
Introduction
- It would be helpful to mention that the ELIXIR Services can be data resources, tools, and services.
- It is mentioned that the selection process aims to reflect national strengths and priorities in
bioinformatics and engage its national community. For readers who are not familiar with the bioinformatics
community in the UK, it would be helpful to include a short, general description of the local bioinformatics
landscape.
Process overview
- Is "3. Setting up appropriate structures" referring to the Scientific Development Group or does it include
other structures?
- Which are the Working Groups that are mentioned in Figure 1 (you mention the Agriculture-related data
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 - Which are the Working Groups that are mentioned in Figure 1 (you mention the Agriculture-related data
WG)?
Strategic Prioritization
- When you refer to "ELIXIR-UK", or "discussions within the Node", is this the same as "ELIXIR-UK
Executive" in Figure 1 and the Executive Committee (http://www.elixir-uk.org/about-the-node)?
Assessment criteria
- There is a mix here between the criteria for the ELIXIR Services (brought forward by the ELIXIR Nodes
through the Service Delivery Plans) and the indicators which have been developed for the ELIXIR Core
Data Resources. The latter focus on databases only and therefore won't be very helpful for training (for
example). It would be good to make this explicit to avoid any potential confusion.
Results of the assessment
- The list of assessment criteria is long and broad in scope. Is there any way of summarizing on which
criteria the UK services are doing particularly well and on which criteria there can be improvement (or that
were reasons for not including the services)?
- Table 2: the services that are listed, seem to be UK-only. Certain are however broader collaborations
(e.g. Ensembl, TeSS). Could this be made clear?
Future activities and conclusions
- From the text, it seems that ELIXIR-UK is focusing on the identification of the ELIXIR UK Services. Is the
UK node offering specific support (or other) to its services?
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard.
 No competing interests were disclosed.Competing Interests:
Author Response (   ) 27 Mar 2017Member of the F1000 Faculty
, ELIXIR-UK Group, Earlham Institute, UKJohn Hancock
In response to this reviewer:
As also requested by another reviewer we now mention that ELIXIR Services can be data
resources, tools, and services
 
Included a brief overview of the UK bioinformatics landscape, including its funding
landscape
 
Clarified the meaning of point 3: "Setting up appropriate structures"; in relation to working
groups we only established the Agriscience working group in this round of the process
although we might establish others in future
 
Clarified (as also raised by another reviewer) that internal discussions within the Node
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 Clarified (as also raised by another reviewer) that internal discussions within the Node
primarily involved the Node Executive
 
Clarified the relationship of the assessment criteria to training resources
 
Made a brief comment on why some resources were not accepted immediately as Node
resources
 
Commented on how we treated resources that were international collaborations
 
Commented on how we propose to support Node resources in future
 
We hope these comments are helpful. 
 NoneCompeting Interests:
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